California Public Employees Retirement System Sells 8,300 Shares of Zeltiq Aesthetics Inc. (ZLTQ)
California Public Employees Retirement System cut its position in shares of Zeltiq Aesthetics Inc. (NASDAQ:ZLTQ) by 10.1% during the second quarter, Holdings Channel reports. The firm owned 73,600 shares of the company’s stock after selling 8,300 shares during the period. California Public Employees Retirement System owned approximately 0.19% of Zeltiq Aesthetics worth $2,012,000 as of its most recent SEC filing.
Several other hedge funds have also bought and sold shares of ZLTQ. Emerald Acquisition Ltd. acquired a new stake in Zeltiq Aesthetics during the second quarter worth about $4,664,000. Swiss National Bank increased its stake in Zeltiq Aesthetics by 12.8% in the second quarter. Swiss National Bank now owns 59,800 shares of the company’s stock worth $1,634,000 after buying an additional 6,800 shares during the period. Quantitative Investment Management LLC acquired a new stake in Zeltiq Aesthetics during the second quarter worth about $1,134,000. New Jersey Better Educational Savings Trust increased its stake in Zeltiq Aesthetics by 22.2% in the second quarter. New Jersey Better Educational Savings Trust now owns 22,000 shares of the company’s stock worth $601,000 after buying an additional 4,000 shares during the period. Finally, State of New Jersey Common Pension Fund D acquired a new stake in Zeltiq Aesthetics during the second quarter worth about $6,559,000.
Zeltiq Aesthetics Inc. (NASDAQ:ZLTQ) traded up 1.17% during trading on Thursday, reaching $40.64. 426,743 shares of the company’s stock were exchanged. Zeltiq Aesthetics Inc. has a 12 month low of $18.41 and a 12 month high of $41.43. The firm’s 50-day moving average price is $38.56 and its 200-day moving average price is $31.71. The firm has a market cap of $1.61 billion, a price-to-earnings ratio of 61.11 and a beta of 0.79.
Zeltiq Aesthetics (NASDAQ:ZLTQ) last issued its earnings results on Monday, August 8th. The company reported ($0.12) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.05) by $0.07. Zeltiq Aesthetics had a negative return on equity of 9.90% and a net margin of 9.54%. The firm had revenue of $89.50 million for the quarter, compared to analyst estimates of $79.68 million. During the same period in the previous year, the company earned $0.03 earnings per share. Zeltiq Aesthetics’s revenue for the quarter was up 38.9% compared to the same quarter last year. On average, equities research analysts anticipate that Zeltiq Aesthetics Inc. will post ($0.13) EPS for the current year.
A number of analysts have recently issued reports on the stock. Stifel Nicolaus lifted their price objective on shares of Zeltiq Aesthetics from $38.00 to $52.00 and gave the company a “buy” rating in a report on Wednesday, September 21st. Leerink Swann reiterated an “outperform” rating and issued a $48.00 price objective on shares of Zeltiq Aesthetics in a report on Thursday, August 25th. Zacks Investment Research upgraded shares of Zeltiq Aesthetics from a “sell” rating to a “hold” rating in a report on Friday, August 12th. JPMorgan Chase & Co. reissued a “hold” rating and issued a $35.00 target price (up from $27.00) on shares of Zeltiq Aesthetics in a research note on Tuesday, August 9th. Finally, Brean Capital set a $39.00 target price on shares of Zeltiq Aesthetics and gave the company a “buy” rating in a research note on Tuesday, August 9th. Three equities research analysts have rated the stock with a hold rating, eight have given a buy rating and one has assigned a strong buy rating to the company. The stock currently has a consensus rating of “Buy” and a consensus price target of $39.89.
In other news, insider Keith J. Sullivan sold 8,000 shares of the company’s stock in a transaction that occurred on Monday, July 11th. The stock was sold at an average price of $30.02, for a total transaction of $240,160.00. Following the transaction, the insider now directly owns 77,922 shares of the company’s stock, valued at $2,339,218.44. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Andrew N. Schiff sold 500,000 shares of the company’s stock in a transaction that occurred on Thursday, August 11th. The stock was sold at an average price of $36.39, for a total value of $18,195,000.00. The disclosure for this sale can be found here. Insiders own 15.60% of the company’s stock.
About Zeltiq Aesthetics
ZELTIQ Aesthetics, Inc is a medical technology company. The Company focuses on developing and commercializing products utilizing its controlled-cooling technology platform. Its product, the CoolSculpting System, is designed to reduce stubborn fat bulges. It sell the CoolSculpting system primarily to dermatologists, plastic surgeons, aesthetic specialists, and obstetrics and gynecology physicians.
Want to see what other hedge funds are holding ZLTQ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zeltiq Aesthetics Inc. (NASDAQ:ZLTQ).
Receive News & Ratings for Zeltiq Aesthetics Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zeltiq Aesthetics Inc. and related companies with MarketBeat.com's FREE daily email newsletter.